Patents by Inventor Amanda Corteyn

Amanda Corteyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Excipients for stabilising viral particles, polypeptides or biological material
    Patent number: 10716859
    Abstract: A sterile pharmaceutically acceptable aqueous solution, which solution is provided in a sealed container and comprises: a pharmaceutically acceptable aqueous solvent; viral particles or a physiologically active polypeptide; an excipient selected from a polyethyleneimine; a compound of formula (I) or a physiologically acceptable salt or ester thereof; or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and optionally, one or more sugars.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: July 21, 2020
    Assignee: Stabilitech Biopharma Ltd
    Inventors: Jeffrey Drew, David Thomas Woodward, John Bainbridge, Amanda Corteyn
  • STABILISATION OF VIRAL PARTICLES
    Publication number: 20190307819
    Abstract: A method for preserving viral particles comprising: (a) providing an aqueous solution of (i) viral particles, (ii) optionally one or more sugars, and (iii) a compound of formula (I) or a physiologically acceptable salt or ester thereof and/or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and (b) drying the solution to form a composition incorporating said viral particles.
    Type: Application
    Filed: January 2, 2019
    Publication date: October 10, 2019
    Inventors: Jeffrey DREW, David WOODWARD, John BAINBRIDGE, Amanda CORTEYN
  • Stabilisation of viral particles
    Patent number: 10206960
    Abstract: A method for preserving viral particles comprising: (a) providing an aqueous solution of (i) viral particles, (ii) optionally one or more sugars, and (iii) a compound of formula (I) or a physiologically acceptable salt or ester thereof and/or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and (b) drying the solution to form a composition incorporating said viral particles.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: February 19, 2019
    Assignee: Stabilitech Biopharma Ltd
    Inventors: Jeffrey Drew, David Woodward, John Bainbridge, Amanda Corteyn
  • EXCIPIENTS FOR STABILISING VIRAL PARTICLES, POLYPEPTIDES OR BIOLOGICAL MATERIAL
    Publication number: 20160317665
    Abstract: A sterile pharmaceutically acceptable aqueous solution, which solution is provided in a sealed container and comprises: a pharmaceutically acceptable aqueous solvent; viral particles or a physiologically active polypeptide; an excipient selected from a polyethyleneimine; a compound of formula (I) or a physiologically acceptable salt or ester thereof; or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and optionally, one or more sugars.
    Type: Application
    Filed: May 5, 2016
    Publication date: November 3, 2016
    Inventors: Jeffrey DREW, David Thomas WOODWARD, John BAINBRIDGE, Amanda CORTEYN
  • Method for preserving alum adjuvants and alum-adjuvanted vaccines
    Patent number: 9101607
    Abstract: A method for preserving an aluminium-salt adjuvant during freezing or drying comprising freezing or drying an aqueous suspension or solution comprising: (a) an aluminium salt adjuvant; (b) a compound of formula (I) or a physiologically acceptable salt or ester thereof or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and (c) optionally, one or more sugars.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: August 11, 2015
    Assignee: Stabilitech Ltd.
    Inventors: Jeffrey Drew, David Woodward, Amanda Corteyn
  • Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
    Publication number: 20130164296
    Abstract: A sterile pharmaceutically acceptable aqueous solution, which solution is provided in a sealed container and comprises: a pharmaceutically acceptable aqueous solvent; viral particles or a physiologically active polypeptide; an excipient selected from a polyethyleneimine; a compound of formula (I) or a physiologically acceptable salt or ester thereof; or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and optionally, one or more sugars.
    Type: Application
    Filed: March 31, 2011
    Publication date: June 27, 2013
    Inventors: Jeffrey Drew, David Woodward, John Bainbridge, Amanda Corteyn
  • Method for Preserving Alum Adjuvants and Alum-Adjuvanted Vaccines
    Publication number: 20130156797
    Abstract: A method for preserving an aluminium-salt adjuvant during freezing or drying comprising freezing or drying an aqueous suspension or solution comprising: (a) an aluminium salt adjuvant; (b) a compound of formula (I) or a physiologically acceptable salt or ester thereof or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and (c) optionally, one or more sugars.
    Type: Application
    Filed: March 31, 2011
    Publication date: June 20, 2013
    Applicant: Stabilitech Ltd.
    Inventors: Jeffrey Drew, David Woodward, Amanda Corteyn
  • Stabilisation of Viral Particles
    Publication number: 20130129685
    Abstract: A method for preserving viral particles comprising: (a) providing an aqueous solution of (i) viral particles, (ii) optionally one or more sugars, and (iii) a compound of formula (I) or a physiologically acceptable salt or ester thereof and/or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and (b) drying the solution to form a composition incorporating said viral particles.
    Type: Application
    Filed: March 31, 2011
    Publication date: May 23, 2013
    Applicant: STABILITECH LTD.
    Inventors: Jeffrey Drew, David Woodward, John Bainbridge, Amanda Corteyn